Clinical Trials on Subcutaneous Tumor in France

Total 1949 results

Oncoethix GmbH

Unknown

A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors

Solid Tumors

Belgium, France
Federation Francophone de Cancerologie Digestive

Recruiting

Cohort of Tumors With POLE/D1 Mutation

Tumors | POLD1 Gene Mutation | POLE Exonuclease Domain Mutation

France
Institut Claudius Regaud

Completed

Evaluation of the Impact of a Follow-up Phone Call Nurse Device in the Care of Patients With Chemotherapy Treatment (EVAL'COACH)

Solid Tumors

France
Institut Curie

Unknown

A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer (SHIVA)

Reccurent/Metastatic Solid Tumor Disease

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Diaphyseal Reconstruction of Malignant Tumors in Children (RDTM)

Childhood Malignant Tumors of Lower Limbs

France
Institut Curie

Recruiting

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) (MICCHADO)

Leukemia | Osteosarcoma | Neuroblastoma | Rhabdomyosarcoma | Central Nervous System Tumor | Ewing Sarcoma Family of Tumors

France
Kyowa Kirin, Inc.

Completed

KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors

Carcinoma | Cancer | Solid Tumor

United States, France
Centre Antoine Lacassagne

Completed

Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal Wire (IodineBreast)

Breast Cancer

France
Centre Leon Berard
Roche Pharma AG

Completed

Evaluation of the Added Value of a Large Molecular Profiling Panel Versus a Limited Molecular Profiling Panel in Advanced Solid Tumors. (PROFILER 02)

Advanced Solid Tumor

France
European Organisation for Research and Treatment...

Completed

Ph II CABOGIST in GIST

Metastatic Gastrointestinal Stromal Tumor

France, United Kingdom, Belgium, Czechia, Germany, Hungary
National Cancer Institute (NCI)
Children's Cancer Group

Completed

Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor

Sarcoma | Neutropenia

United States, Puerto Rico, Canada, Switzerland, Australia
University of Avignon
Assistance Publique Hopitaux De Marseille; Centre Hospitalier Henri Duffaut...

Terminated

Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT) (MICROBAT)

Pheochromocytoma | Paraganglioma

France
Centre Hospitalier Universitaire de Nice

Completed

Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children (NAUVOLA)

Chemotherapy-induced Nausea and Vomiting | Children | Malignant Tumor

France
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma (TRANSPHIL)

Cholangiocarcinoma

France
Institut de cancérologie Strasbourg Europe

Completed

Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT) (RESPECT)

Hematologic Malignancy | Tumor, Solid

France
Assistance Publique - Hôpitaux de Paris
Society for Endocrinology

Recruiting

In Vivo Succinate Detection After External Beam Radiation Therapy in SDHx- Paragangliomas (RADIOSUCCES)

Paraganglioma of Head and Neck

France
CHU de Reims

Completed

Molecular Characterization of Advanced Stage Melanoma by Blood Sampling (MELCIRC)

Metastatic Melanoma

France
Nantes University Hospital
UMR892

Completed

Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study (MelSort)

Metastatic Melanoma

France
CHU de Reims

Unknown

Molecular Characterization of Primary Mucosal Melanoma (MELMUQ)

Mucosal Melanoma

France
University Hospital, Caen

Completed

Study Multicentre Evaluating the Effectiveness and Toxicity Sorafenib (Nexavar®) in Adult Patients With Uveal Melanoma and Metastatic Dissemination (O-Mel-Sora)

Uveal Melanoma

France
Assistance Publique Hopitaux De Marseille

Unknown

Study of Risk Factors and Clinical Characterization of Rapidly Growing Melanoma

Melanoma Cancer

France
Institut Curie

Unknown

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Intraocular Melanoma

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or Paraganglioma (e-PPGL)

Pheochromocytoma | Paraganglioma

France
Institut Curie

Completed

Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU) (ctDNA MU)

Choroidal Melanoma

France
Centre Hospitalier Universitaire de Nice

Completed

Study of Molecular Mechanisms Implicated in the Pathogenesis of Melanoma. Role of Exosomes (EXOSOMES)

Metastatic Melanoma

France
Assistance Publique Hopitaux De Marseille

Completed

Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study

Metastatic Melanoma

France
University Hospital, Grenoble
Etablissement Français du Sang

Recruiting

Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients (PHENOMENAL)

Melanoma

France
University Hospital, Strasbourg, France

Not yet recruiting

PRAME Immunohistochemistry as an Adjunct for Evaluating Ambiguous Melanocytic Proliferation (ANTIPRAME)

Melanoma

France
Institut Claudius Regaud

Completed

TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma (TICIMEL)

Melanoma

France
Centre Hospitalier Universitaire de Besancon
Centre Georges Francois Leclerc

Active, not recruiting

Analysis of Circulating Exosomes in Melanoma Patients (EXOMEL1)

Melanoma

France
Bristol-Myers Squibb

Active, not recruiting

A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France (AdjuMel)

Melanoma

France
Centre Oscar Lambret

Recruiting

Feasibility of a New Technology for Isolating Circulating Tumour Cells (CTC-SMMiL-E)

Ovarian Cancer | Hormone-resistant Prostate Cancer | Circulating Tumor Cell | HER2-positive Metastatic Breast Cancer

France
Ipsen

Completed

BN80927 in Patients With Advanced Malignant Solid Tumors

Malignant Solid Tumour

France
Elro Pharma

Completed

Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IPP-204106N on Advanced Solid Tumors (IP N02)

All Solid Tumors

France, Belgium
Centre Leon Berard
University of Paris 5 - Rene Descartes; Institut d'Hématologie et d'Oncologie...

Recruiting

Supportive Care Needs of Former Child, AYA Cancer Patients, and of Their Parents: Evaluation During Long-term Follow-up (ExPEDAJAC)

Solid Tumor or Lymphoma

France
Navire Pharma Inc., a BridgeBio company
Amgen

Recruiting

SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation (Argonaut)

Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLC

Spain, Australia, France, Denmark, Greece, Italy, Netherlands
Assistance Publique Hopitaux De Marseille

Completed

Feasibility of 123I-IBZM Scintigraphy (a D2 Agonist) in Patients With Pheochromocytoma (PHEO) and/or Paraganglioma (PGL) : Study Pilot

Chromaffin-tissue Derived Tumors

France
4SC AG

Completed

Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1 (MERKLIN2)

Merkel Cell Carcinoma

Spain, Netherlands, Belgium, Germany, France, Italy
Hospices Civils de Lyon

Unknown

Surgeon-Anesthesiologist Collaboration (CCAP)

Pheochromocytoma | Collaboration

France
Assistance Publique - Hôpitaux de Paris

Completed

Multicentric Cohort of Melanoma Patients in Ile de France Area (Melan-Cohort)

Melanoma | Genetic Polymorphism

France
Swiss Group for Clinical Cancer Research

Completed

Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumor

France, Switzerland, Germany, Finland
Henri Mondor University Hospital

Recruiting

Detecting the Rest Tremor Associated With Parkinson's Disease Using Analysis of the Muscle Contractions Rhythmicity (TREMORHYTHM)

Diagnoses Disease | Parkinson | Rest Tremor | Cerebellar Tumor | Movement; Abnormal, Involuntary

France
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

Symptomatic Refractory Resistant Carcinoid Disease

United Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
Institut Claudius Regaud
Merck Sharp & Dohme LLC

Terminated

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Malignant Solid Tumour

France
Institut Curie

Completed

Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

Choroidal Melanoma, Diffuse

France
Centre Leon Berard

Recruiting

Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer (HOPAYA)

Lymphoma | Solid Tumor

France
Epizyme, Inc.

Completed

A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

Synovial Sarcoma | INI1-negative Tumors | Malignant Rhabdoid Tumor of Ovary | Rhabdoid Tumors

United States, France, Canada, Italy, Germany, United Kingdom, Australia, Denmark, Netherlands
Hoffmann-La Roche

Completed

An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study

Solid Tumor

Spain, Russian Federation, France, Japan, South Africa, Latvia, Serbia, Italy
Merck Sharp & Dohme LLC

Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Melanoma | Lymphoma | Solid Tumor | Classical Hodgkin Lymphoma | Microsatellite-instability-high Solid Tumor

France, Germany, Italy, Netherlands, Sweden, United Kingdom, Brazil, Israel, Korea, Republic of, United States
DeuterOncology

Recruiting

Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours

Adult Solid Tumor | Lung Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Non-small Cell Carcinoma | Refractory Tumor | Hereditary Renal Papillary Cancer

France, Belgium, Netherlands

Clinical Trials on Subcutaneous Tumor in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations